ST
Shattuck Labs, Inc.
STTK · NASDAQ
$5.86 -9.85% (-$0.64)
1M +0.00%
Market Cap $587.4M
P/E Ratio -
Div. Yield -
ROE 43.57%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
35 /100
Fair P/B 2.78x
P/S 587.42x
EV/EBITDA N/A
Growth
69 /100
Growing Book val. growth 22.38%
Rev. growth 15.32%
FCF growth N/A
Profitability
0 /100
Weak Net margin 5,256.80%
Op. margin 5,578.70%
FCF margin 4,124.00%
Quality
0 /100
Poor ROE 43.57%
ROA 23.82%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 27.59x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
46 /100
Moderate Rev. volatility 169.19%
EPS volatility 19.43%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o STTK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Taylor H. Schreiber
Employees
40
Headquarters
Austin
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report